Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue-Reference-Cited by-同舟云学术

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue

Published:2020-07-04 Issue:3 Volume:16 Page:404-414
ISSN:2225-3653
Container-title:Rational Pharmacotherapy in Cardiology
language:
Short-container-title:Racionalʹnaâ farmakoterapiâ v kardiologii

Author:

Ostroumova O. D.¹,Goloborodova I. V.²

Affiliation:

1. Russian Medical Academy of Continuous Professional Education; I.M. Sechenov First Moscow State Medical University (Sechenov University)

2. A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference67 articles.

1. Piran S., Schulman S. Management of venous thromboembolism: An update. Thromb J. 2016;14:107-15. DOI:10.1186/s12959-016-0107-z.

2. Granger C.B., Alexander J.H., McMurray J.J., et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-92. DOI:10.1056/NE-JMoa1107039.

3. Connolly S.J., Eikelboom J., Joyner C., et al. AVERROES Steering Committee Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364:806-17. DOI:10.1056/NEJMoa1007432.

4. Hylek E.M., Held C., Alexander J.H., et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014;63:2141-7. DOI:10.1016/j.jacc.2014.02.549.

5. Flaker G.C., Eikelboom J.W., Shestakovska O., et al. Bleeding during treatment with aspirin versus apix-aban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial. Stroke. 2012;43:3291-7. DOI:10.1161/STROKEAHA.112.664144.